Study of Roxadustat in the Treatment of Acute Myocardial Infarction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 158 participants.

Also called NCT04803864

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 158 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04803864
Other papers using this trial's data
  • Roxadustat Treatment After PCI Among Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial JAMA network open, 2026-10-01 DOI, PubMed 42853570, PMC13653278 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04803864. Randomized; single masking; primary purpose treatment. Start 2021-06-10 (actual); primary completion 2022-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Roxadustat in the Treatment of Acute Myocardial Infarction
Acronym
ROXAMI
Condition
ST Elevation Myocardial Infarction
Intervention (Drug)
Roxadustat
Lead sponsor
Ruijin Hospital (class: other)

Record details

Record id
cardio:ct-nct04803864
Content hash
600903d35da212b01407929faf61b2b67de6a1ca0b5f0e4617cec1ebf4cecdc6